Saturday, October 31, 2026

Air Products to Remove $8.4B Saudi Green Hydrogen Project from Balance Sheet

Air Products will deconsolidate its NEOM green hydrogen joint venture when the $8.4 billion facility starts operations by mid-2027. The accounting shift removes project debt from the US industrial gas supplier's books while maintaining its 33.3% stake in what will be one of the world's largest green hydrogen plants.

ViaNews Editorial Team

February 21, 2026

Source Trace Score1 source document1 with a live linkVerifiability: Basic
Air Products to Remove $8.4B Saudi Green Hydrogen Project from Balance Sheet
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Air Products plans to deconsolidate its NEOM green hydrogen joint venture by June 30, 2027, removing $8.4 billion in project assets and liabilities from its consolidated balance sheet. The Pennsylvania-based industrial gas supplier will shift to equity method accounting when the Saudi Arabian facility begins commercial operations.

The project ranks among the first mega-scale green hydrogen facilities globally. The plant will produce 650 tons of green hydrogen daily using 4 gigawatts of renewable energy from solar and wind sources in northwest Saudi Arabia. Air Products holds a 33.3% stake alongside Saudi partners ACWA Power and NEOM.

Deconsolidation means Air Products will record only its proportionate share of the venture's net income rather than including all assets and liabilities. The change removes $5.6 billion in project debt from consolidated statements, improving the company's debt-to-equity ratio. Air Products' equity investment totals approximately $2.8 billion.

ACWA Power will manage plant operations while Air Products supplies the technology and offtakes the green ammonia for global distribution. The hydrogen feeds an onsite ammonia production unit designed for easier international transport. Commercial production depends on completing electrolyzer installation across NEOM's 26,500 square kilometer development zone.

The accounting treatment mirrors structures Air Products uses for other large-scale hydrogen projects in development worldwide. Management disclosed the timing in Q1 2025 earnings materials, citing the JV structure and operating agreements as factors triggering the change. Analysts expect enhanced financial metrics without altering economic exposure to the venture.

The NEOM facility's operational timeline positions Saudi Arabia as an early mover in industrial-scale green hydrogen production. The project targets export markets across Europe and Asia where countries are building hydrogen import infrastructure to meet decarbonization goals.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score1 source document1 with a live linkVerifiability: Basic
  1. [1]News articleYahoo Finance· January 30, 2026
    Air Products and Chemicals Q1 Earnings Call Highlights
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com